|
Efamol Efalex
Nutrivene Products : Essential Fatty Acids (DHA/GLA/Other Combination)
 |
In nursing infants, visual and cognitive development is associated with an adequate supply of two fatty acids in particular, docosahexaenoic acid (DHA) and arachidonic acid (AA).(1,2) Most school age children find focusing and learning easy.(3) A majority of those that don't are boys, who naturally have a higher requirement for essential fatty acids than girls.(4) Normal body levels of DHA and AA are associated with normal behavior (5,6,11) and sleep patterns,(8) and typical visual, auditory, language and reading performance.(7) As well, normal reading, spelling and auditory working memory (9,10) are correlated with healthy skin and nails, an indication of normal body fatty acid composition. Maintaining certain levels of DHA and AA is vital to promote and maintain eye (12,13) and brain health and function. Supplementing the diet with Efalex is a convenient way to ensure intake of these important nutrients that support and maintain healthy mental function and focus.(14,15)*
Efalex contains 240 mg of DHA, 48 mg of Gamma Linolenic Acid, 351 mg of Linoleic Acid, 22.4 IU of Vitamin E, 18 mg of Arachidonic Acid, and 3.9 mg of Thyme Oil (per 3 gelcaps). Other ingredients include gelatin and glycerine.
Efalex gelcaps can be swallowed or the capsules may be cut open or pierced with a pin and the contents mixed with foods and drinks, or alternatively may be given with on a spoon. (180 gelcaps per bottle)
Dosage: Children 2 to 5 years of age, take 1-3 gelcaps per day with food or drink. Adults and children 5 years and older, take 2-3 gelcaps per day with food or drink or as recommended by your physician or other healthcare provider. Taking this product for the first time: The amounts should be doubled for the first 12 weeks.
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
(1) Innis SM. J Pediatr 2003;143 (4 Suppl):
S1-8
(2) Larque E, Demmelmair H, Koletzko B Ann
N.Y. Acad Sci. 2002;967:299-310
(3) Stevens LJ, Zentall SS, Deck JL, Abate
ML Watkins BA, Lipp SR.Am J Clin Nutr
1995;62:761-8
(4) Colquhoun I, Bunday S. Medical
Hypotheses 1981;7:673-679
(5) Mitchell EA, Lewis S, Cutler DR.
Prostaglandins Leukotrienes and
Medicine 1983;12:281-287
(6) Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang
SC. J Nutr Biochem 2004;15(8):467-72
(7) Mitchell EA, Aman MG, Turbott SH, Manku
M. Clinical Pediatrics. 1987 Aug;26
(8):406-11.
(8) Stevens LJ, Zentall SS, Abate ML,
Kuczek T, Burgess JR. Physiology &
Behavior. 1996; Vol. 59, No 4/5:
915-920.
(9) Taylor KE, Higgins CJ, Calvin CM, Hall
JA, Easton T, McDaid AM et al.
Prostaglandins Leukotrienes and
Essential Fatty Acids. 2000;63(1/2):75- 78
(10) Richardson AJ, Calvin CM, Clisby C,
Schoenheimer DR, Montgomery P, Hall JA.
Prostaglandins Leukotrienes and
Essential Fatty Acids. 2000;63(1/2):69- 74
(11) Burgess JR, Stevens L, Zhang W, Peck
L. Am J Clin Nutr2000:71(suppl):327S-
30S
(12) Stordy BJ. Am J Clin Nutr 2000;71
(suppl):323S-6S
(13) Stordy BJ. The Lancet 1995;Vol. 346 No.
8971: 385
(14) Richardson AJ, Puri BK. Progress in
Neuro-Psychopharmacology & Biological
Psychiatry. 2002;26:233-239
(15) Stevens L, Zhang W, Peck L, Kuczek T,
Grevstad N, Mahon A et al. Lipids
2003;38(10):1007-1021
$27.95
|
.jpg)
